Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma

Figure 11  Sensitivity analysis of Rho GTPase activating protein 12 to tyrosine kinase inhibitors and immunotherapy. A: Relationship between Rho GTPase activating protein 12 expression and immune escape, immunotherapy; B: Relationship between Rho GTPase activating protein 12 expression and the intensity of tyrosine kinase inhibitors treatment. ARHGAP12: Rho GTPase activating protein 12.